Healthcare Network
-
Healthcare Network The 16th meeting
- Osaka
- Number of participants 28 participants
Subject
- The direction of generic producer
- The growth strategy of by-business pharmaceutical company
- The marketing strategy of the healthcare safety AI system DeepSafety®︎
-
Healthcare Network The 20th meeting
- Tokyo
- Number of participants 30 participants
Subject
- The challenge of new value for complex pharmaceutical conglomerates
- Pros and cons of preventive healthcare
- The meaning and the scheme of enhancing corporate reputation among healthcare-related companies
-
Healthcare Network The 18th meeting
- Tokyo
- Number of participants 40 participants
Subject
- The dilemma of the pharmaceutical company
- How to utilize and commercialize the text analyzing AI in healthcare / medical industry
- The entry into a new market and the challenge of the deserted electroencephalograph
-
Healthcare Network The 14th meeting
- Osaka
- Number of participants 16 participants
Subject
- The expectation and the challenge in the application of genome editing to healthcare and drug development
- What if the “sharing economy” is applied to healthcare industry?
- Discussing the reform of working practices
-
Healthcare Network The 14th meeting
- Nagoya
- Number of participants 24 participants
Subject
- The beginning of big consolidation of acute hospitals? The present and the future of the local healthcare concept and hospital governance
- What is the customer value (product) at the dental clinic?
- What if the “sharing economy” is applied to healthcare industry?
-
Healthcare Network The 13th meeting
- Nagoya
- Number of participants 19 participants
Subject
- The survival and growth of generic producers in the era of generic consisting of 80%
- Discussing the reform of working practices
- Major pharmaceutical company “conquering the two cannibalizations”
-
Healthcare Network The 17th meeting
- Tokyo
- Number of participants 50 participants
Subject
- Discussing the problems among the domestic pharmaceutical companies, using the new business model of Takeda Pharmaceutical Company Limited as a base
- The strategy of consumer healthcare and pharmaceutical companies
- The condition for a happy marriage – requirements for a manager appearing in the strategic alliance between Chugai and Roche –
-
Healthcare Network The 13th meeting
- Osaka
- Number of participants 33 participants
Subject
- Insurance dispensing pharmacy 10 years from now
- The promotion strategy for medical goods in digital age
- Border survey among job types in a hospital (interim report)
- Considering the cancer check (pre-survey report)
-
Healthcare Network The 12th meeting
- Nagoya
- Number of participants 24 participants
Subject
- “Share value of new medicines” – merits and demerits of co-development / co-promotion –
- Creation of the new healthcare market based on the value of using block-chain technology (virtual currency)
- A family company in Doshomachi, Osaka – Chobei Takeda and Komebei Onoichi
-
Healthcare Network The 12th meeting
- Osaka
- Number of participants 30 participants
Subject
- The foresight and distress of outpatient pediatrics
- Consider new services and challenges which patient-centered digital solution can solve
- The activity and evaluation norms of the clinical engineering department in a hospital affiliated with a medical school in the Kansai region
- The status of HKR project (continuing discussion)
-
Healthcare Network The 16th meeting
- Tokyo
- Number of participants 35 participants
Subject
- The continuous growth of a pharmaceutical company – view from the MR –
- The needs of healthcare in Thailand, Myanmar, Cambodia and Vietnam: for new business development
- The strategy that a local organization in a global CRO should adopt
-
Healthcare Network The 11th meeting
- Osaka
- Number of participants 32 participants
Subject
- To achieve a paradigm shift in health care (the fight against the unconscious bias)
- How to share and provide limited resources (human/ function/ service) effectively in proceeding with local healthcare
- From analyzing the research style of pharmaceutical industry to the creation of new medicine in the 21st century style
- Selecting the theme for HKR project (continuing discussion)